Company Name: Coherus BioSciences, Inc.

Coherus BioSciences, Inc. is engaged in the development and commercialization of biosimilar therapeutics. The company’s therapeutic franchises include:

  • Oncology biosimilar candidates
  • Immunology (anti-TNF) biosimilar candidates
  • Ophthalmology biosimilar candidate
  • Multiple sclerosis (MS) small molecule therapeutic candidate

Ticker Symbol: CHRS (NASDAQ)

Company Website:

Social Media: Coherus BioSciences LinkedIn

Headquarters: Redwood City, California